Results 1 to 1 of 1

Thread: 23andMe's Pharma Deals

  1. #1
    Senior Member SaxonPagan's Avatar
    Join Date
    Oct 2009
    Last Online
    1 Minute Ago @ 11:19 AM
    English, Anglo-Saxon
    England England
    South Coast
    Zodiac Sign
    Self Employed
    Free Speech / Anti-EU
    Thanks Thanks Given 
    Thanks Thanks Received 
    Thanked in
    1,288 Posts

    23andMe's Pharma Deals

    23andMe's Pharma Deals Have Been the Plan All Along

    'Since the launch of its DNA testing service in 2007, genomics giant 23andMe has convinced more than 5 million people to fill a plastic tube with half a teaspoon of saliva. In return for all that spit (and some cash too), customers get insights into their biological inheritance, from the superficial—do you have dry earwax or wet?—to mutations associated with disease. What 23andMe gets is an ever-expanding supply of valuable behavioral, health, and genetic information from the 80 percent of its customers who consent to having their data used for research.

    So last week’s announcement that one of the world’s biggest drugmakers, GlaxoSmithKline, is gaining exclusive rights to mine 23andMe’s customer data for drug targets should come as no surprise. (Neither should GSK’s $300 million investment in the company). 23andMe has been sharing insights gleaned from consented customer data with GSK and at least six other pharmaceutical and biotechnology firms for the past three and a half years. And offering access to customer information in the service of science has been 23andMe’s business plan all along, as WIRED noted when it first began covering the company more than a decade ago.

    But some customers were still surprised and angry, unaware of what they had already signed (and spat) away. GSK will receive the same kind of data pharma partners have generally received—summary level statistics that 23andMe scientists gather from analyses on de-identified, aggregate customer information—though it will have four years of exclusive rights to run analyses to discover new drug targets. Supporting this kind of translational work is why some customers signed up in the first place. But it’s clear the days of blind trust in the optimistic altruism of technology companies are coming to a close.

    “I think we’re just operating now in a much more untrusting environment,” says Megan Allyse, a health policy researcher at the Mayo Clinic who studies emerging genetic technologies. “It’s no longer enough for companies to promise to make people healthy through the power of big data.” Between the fall of blood-testing unicorn Theranos and Facebook’s role in the 2016 election attacks, “I think everything from here on out will be subject to much higher levels of public scrutiny,” Allyse says.

    23andMe maintains that transparency is a core tenet of the company. “I think a really important distinction to make is that 23andMe operates under an independent ethical review board that oversees all of our research,” says Emily Drabant Conley, 23andMe’s vice president of business development, who oversaw the announcement of the GSK deal. “The guidelines we follow are essentially the same as what other research institutions follow.” So they should apply to any of the analyses GSK might want to run on 23andMe data, like a PheWAS, which connects constellations of symptoms and conditions across many people with a single genetic mutation they all share.'

  2. The Following User Says Thank You to SaxonPagan For This Useful Post:

Similar Threads

  1. 23andMe Christmas Sale
    By Magni in forum Genealogy & Ancestry DNA
    Replies: 44
    Last Post: Thursday, August 9th, 2012, 02:26 PM
  2. Relative Finder on 23andme
    By Hesse in forum Genealogy & Ancestry DNA
    Replies: 11
    Last Post: Sunday, February 19th, 2012, 09:15 AM
  3. DNA Study Deals Blow to Theory of European Origins
    By Todesritter in forum Anthropogeny & Ethnogenesis
    Replies: 0
    Last Post: Thursday, August 25th, 2011, 12:03 AM
  4. Gall-Gaidheal's 23andme
    By Gall-Gaidheal in forum Genealogy & Ancestry DNA
    Replies: 13
    Last Post: Monday, June 6th, 2011, 11:24 PM


Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts